Trials / Sponsors / Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study in Participants With Advanced Cancers Associated With Expression of DLL3 (MK-6070-001/HPN328-4001) Small-Cell Lung Cancer, Neuroendocrine Carcinoma | Phase 1 / Phase 2 | 2020-12-14 |
| Active Not Recruiting | Study of HPN217 in Participants With Relapsed/Refractory Multiple Myeloma MK-4002 (MK-4002-001) Multiple Myeloma in Relapse, Multiple Myeloma, Multiple Myeloma of Bone | Phase 1 | 2020-04-13 |
| Completed | Study of HPN536 in Patients With Advanced Cancers Associated With Mesothelin Expression Advanced Cancers Associated With Mesothelin Expression | Phase 1 | 2019-04-16 |
| Terminated | Study of HPN424 in Patients With Advanced Prostate Cancer Advanced Prostate Cancer | Phase 1 / Phase 2 | 2018-07-24 |